Insider Transactions
Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jan 29, 2021 |
SVP & Chief Accounting Officer
Trans History: 17
|
SVP & Chief Accounting Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 2,574 | $0.25 | 9,358 |
Jan 20, 2021 |
Director, President
Trans History: 417
|
Director, President | Form 4 | Other acquisition or disposition | -- | -- | 2,100 |
Jan 20, 2021 |
Director, President
Trans History: 417
|
Director, President | Form 4 | Other acquisition or disposition | -- | -- | 700 |
Jan 15, 2021 |
EVP and CFO
Trans History: 74
|
EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 809 | $95.15 | 11,333 |
Jan 15, 2021 |
Director, President
Trans History: 417
|
Director, President | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 729 | $95.15 | 180,763 |
Dec 31, 2020 |
Director
Trans History: 24
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 317 | $94.53 | 2,111 |
Dec 31, 2020 |
Director
Trans History: 34
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 290 | $94.53 | 2,487 |
Dec 31, 2020 |
Director
Trans History: 163
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 251 | $94.53 | 20,961 |
Dec 31, 2020 |
Director
Trans History: 79
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 489 | $94.53 | 8,986 |
Dec 31, 2020 |
Director
Trans History: 94
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 290 | $94.53 | 8,706 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.